Infection Clinical Trial
Official title:
Maternal Cesarian Section Infection (MACSI) in Sierra Leone: an Observational Study
Up to 1 in 5 women in Africa who deliver their baby by cesarean section get a wound
infection.
Surgical site infections (SSIs) are largely preventable, but they represent a considerable
burden for health-care systems, particularly in low-income and middle-income countries. The
prevention of these infections is complex and requires the integration of a range of
preventive measures before, during, and after surgery.
The aim of the proposed project is to determine the risk factors of Surgical Site Infection
post-Cesarean Section in women admitted to Princess Christian Maternity Hospital (PCMH) in
Freetown, Sierra Leone. Secondary aims are to determine the incidence of SSI and the
predictors of a negative outcome in women with post-CS SSI.
Rationale: More than 1 in 10 people who have surgery in low and middle-income countries
(LMICs) get surgical site infection. People's risk of SSI in LMICs is 3 to 5 times higher
than in high-income countries. Up to 1 in 5 women in Africa who deliver their baby by
cesarean section get a wound infection.
Surgical site infections (SSIs) are largely preventable, but they represent a considerable
burden for health-care systems, particularly in low-income and middle-income countries. The
prevention of these infections is complex and requires the integration of a range of
preventive measures before, during, and after surgery.
Objective: The aim of the proposed project is to determine the risk factors of Surgical Site
Infection post-Cesarean Section in women admitted to Princess Christian Maternity Hospital
(PCMH) in Freetown, Sierra Leone. Secondary aims are to determine the incidence of SSI and
the predictors of a negative outcome in women with post-CS SSI.
Study design: This is a prospective case-control (1:3 ratio) study. Study population and
Methods: All women admitted or already hospitalized with suspected or confirmed infection
after C/S will be screened for inclusion in the study as a case. Case confirmation will be
clinically established by an infectious disease expert. For each case, 3 patients undergoing
the C/S on the same day and admitted to the same ward but not presenting SSI, will be
selected as controls.
Sample size: No formal sample size calculation is performed.
Main study parameters/primary endpoints: SSI post C/S will be classified as:
Superficial incisional surgical site infection, Deep incisional surgical site infection;
Organ/space surgical site infection Nature and extent of the burden and risks associated with
participation, benefit, and group relatedness: Because all proceedings in the method of this
study are based on common clinical practice, there are no serious adverse events (SAEs)
expected.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04529421 -
Assocation Between In-person Instruction and COVID-19 Risk
|
||
| Recruiting |
NCT04081792 -
Optimal Antibiotics for Operated Diabetic Foot Infections
|
N/A | |
| Completed |
NCT04332861 -
Evaluation of Infection in Obstructing Urolithiasis
|
||
| Recruiting |
NCT04674657 -
Does Extra-Corporeal Membrane Oxygenation Alter Antiinfectives Therapy Pharmacokinetics in Critically Ill Patients
|
||
| Enrolling by invitation |
NCT05052203 -
Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
|
||
| Recruiting |
NCT00342589 -
New Techniques for Using a Saline Wash as a Diagnostic Tool for Pneumocystis Pneumonia
|
||
| Completed |
NCT03295825 -
Heparin Binding Protein in Early Sepsis Diagnosis
|
N/A | |
| Completed |
NCT03296423 -
Bacillus Calmette-guérin Vaccination to Prevent Infections of the Elderly
|
Phase 4 | |
| Withdrawn |
NCT04217252 -
Clinical Application of High-throughput Sequencing Technology for the Diagnosis of Patients With Severe Infection
|
N/A | |
| Recruiting |
NCT02905552 -
Myelodysplasic Syndromes and Risk Factors for Infection
|
N/A | |
| Recruiting |
NCT02899143 -
Short-course Antimicrobial Therapy in Sepsis
|
Phase 2 | |
| Withdrawn |
NCT02904434 -
Gastrointestinal Implications of Voriconazole Exposure
|
||
| Active, not recruiting |
NCT02768454 -
Antimicrobials Stewardship by Pharmacist
|
N/A | |
| Completed |
NCT02219776 -
Decreasing Infection In Arthroscopic Shoulder Surgery
|
N/A | |
| Completed |
NCT02210169 -
RCT of Continuous Versus Intermittent Infusion of Vancomycin in Neonates
|
N/A | |
| Recruiting |
NCT02098226 -
Evaluation of MALDI Biotyper CA System for Detection of Gram- and Gram+ Bacteria and Yeasts
|
N/A | |
| Completed |
NCT01846832 -
A Study of TMC435 Plus Pegylated Interferon Alfa-2a and Ribavirin in Participants With Chronic HCV Infection
|
Phase 3 | |
| Terminated |
NCT01441206 -
Safety and Pharmacokinetics of Single and Multiple Dose Rifampin in Infants
|
Phase 1 | |
| Completed |
NCT01434797 -
Value of PET/CT Imaging in the Diagnosis of Permanent Central Venous Catheters Infection
|
||
| Completed |
NCT01159834 -
Human Papillomavirus (HPV) Vaccination in Barretos (Pio XII Foundation - Barretos Cancer Hospital)
|
N/A |